Systemic inflammation is dissociated from airflow limitation, and marker-emphysema associations are attenuated by smoking adjustment in stable COPD

Background Chronic obstructive pulmonary disease (COPD) is heterogeneous; whether systemic inflammation tracks the emphysema phenotype, airflow limitation, or cumulative smoking remains unclear. Methods This single-center cross-sectional study enrolled 568 stable COPD patients. Emphysema was defined as a binary variable from radiologist-reported chest computed tomography. Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), neutrophil count, and routine blood indices were analyzed using multivariable logistic regression, Holm-corrected Spearman correlations, and receiver-operating-characteristic analysis. Results The emphysema group ( n = 347) showed nominally higher NLR (2.7 vs. 2.3; p = 0.003), PLR (137.2 vs. 125.0; p = 0.018), and neutrophil count (3.8 vs. 3.5 × 10 9 /L; p = 0.013), with comparable FEV1% predicted ( p = 0.301). After Holm correction, only smoking index and male sex remained significant. Cumulative smoking index (cigarettes/day×years; SD = 536 cigarettes/year) was the strongest independent correlate (OR per SD 2.33, 95% CI 1.78–3.05; corrected p < 0.001); no inflammatory marker retained significance. Excluding 123 never-smokers attenuated nominal inflammatory differences. No marker correlated with FEV1% predicted or FEV1/FVC. A composite score showed limited discriminatory capacity (AUC 0.58, 95% CI 0.53–0.63; cross-validated AUC 0.56). Conclusion In stable COPD, nominal associations between CBC-derived inflammatory markers and the radiologist-defined emphysema phenotype were no longer statistically significant after adjustment for smoking and multiple-testing correction. These markers are also dissociated from spirometric airflow limitation. Cumulative smoking exposure is the strongest independent correlate of emphysema. These findings caution against using routine CBC-derived markers for emphysema phenotyping; prospective studies should determine whether these markers predict exacerbations or FEV1 decline independently of spirometric severity.

Authors

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-12
DOI
https://doi.org/10.3389/fmed.2026.2021422
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Systemic inflammation is dissociated from airflow limitation, and marker-emphysema associations are attenuated by smoking adjustment in stable COPD

Yangzhen Shi, Yan Meihao, 申志勇, Wenying Fan
Frontiers in Medicine
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Systemic inflammation is dissociated from airflow limitation, and marker-emphysema associations are attenuated by smoking adjustment in stable COPD

Yangzhen Shi, Yan Meihao, 申志勇, Wenying Fan
article en

Abstract

Background Chronic obstructive pulmonary disease (COPD) is heterogeneous; whether systemic inflammation tracks the emphysema phenotype, airflow limitation, or cumulative smoking remains unclear. Methods This single-center cross-sectional study enrolled 568 stable COPD patients. Emphysema was defined as a binary variable from radiologist-reported chest computed tomography. Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), neutrophil count, and routine blood indices were analyzed using multivariable logistic regression, Holm-corrected Spearman correlations, and receiver-operating-characteristic analysis. Results The emphysema group ( n = 347) showed nominally higher NLR (2.7 vs. 2.3; p = 0.003), PLR (137.2 vs. 125.0; p = 0.018), and neutrophil count (3.8 vs. 3.5 × 10 9 /L; p = 0.013), with comparable FEV1% predicted ( p = 0.301). After Holm correction, only smoking index and male sex remained significant. Cumulative smoking index (cigarettes/day×years; SD = 536 cigarettes/year) was the strongest independent correlate (OR per SD 2.33, 95% CI 1.78–3.05; corrected p < 0.001); no inflammatory marker retained significance. Excluding 123 never-smokers attenuated nominal inflammatory differences. No marker correlated with FEV1% predicted or FEV1/FVC. A composite score showed limited discriminatory capacity (AUC 0.58, 95% CI 0.53–0.63; cross-validated AUC 0.56). Conclusion In stable COPD, nominal associations between CBC-derived inflammatory markers and the radiologist-defined emphysema phenotype were no longer statistically significant after adjustment for smoking and multiple-testing correction. These markers are also dissociated from spirometric airflow limitation. Cumulative smoking exposure is the strongest independent correlate of emphysema. These findings caution against using routine CBC-derived markers for emphysema phenotyping; prospective studies should determine whether these markers predict exacerbations or FEV1 decline independently of spirometric severity.

Frontiers in MedicineVol. 13
Good health and well-being
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon